Evidence map›Paper›PMID 39348165›Full record

ArticleBioinformatics (Oxford, England)2024

Combined LC-MS/MS feature grouping, statistical prioritization, and interactive networking in msFeaST.

Kevin Mildau, Christoph Büschl, Jürgen Zanghellini, Justin J J van der Hooft

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kevin MildauBioinformatics Group, Department of Plant Sciences, Wageningen University & Research, Radix Building, Droevendaalsesteeg 1, Wageningen, 6708PB, the Netherlands.ORCID 0000-0001-7776-0890
Christoph BüschlDepartment of Agrobiotechnology, Institute of Bioanalytics and Agro-Metabolomics, University of Natural Resources and Life Sciences, Konrad-Lorenz-Straße, Lower Austria 3430, Austria.ORCID 0000-0003-1729-9785
Jürgen ZanghelliniDepartment of Analytical Chemistry, University of Vienna, Vienna 1090, Austria.ORCID 0000-0002-1964-2455
Justin J J van der HooftBioinformatics Group, Department of Plant Sciences, Wageningen University & Research, Radix Building, Droevendaalsesteeg 1, Wageningen, 6708PB, the Netherlands.ORCID 0000-0002-9340-5511

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryComputational metabolomics workflows have revolutionized the untargeted metabolomics field. However, the organization and prioritization of metabolite features remains a laborious process. Organizing metabolomics data is often done through mass fragmentation-based spectral similarity grouping, resulting in feature sets that also represent an intuitive and scientifically meaningful first stage of analysis in untargeted metabolomics. Exploiting such feature sets, feature-set testing has emerged as an approach that is widely used in genomics and targeted metabolomics pathway enrichment analyses. It allows for formally combining groupings with statistical testing into more meaningful pathway enrichment conclusions. Here, we present msFeaST (mass spectral Feature Set Testing), a feature-set testing and visualization workflow for LC-MS/MS untargeted metabolomics data. Feature-set testing involves statistically assessing differential abundance patterns for groups of features across experimental conditions. We developed msFeaST to make use of spectral similarity-based feature groupings generated using k-medoids clustering, where the resulting clusters serve as a proxy for grouping structurally similar features with potential biosynthesis pathway relationships. Spectral clustering done in this way allows for feature group-wise statistical testing using the globaltest package, which provides high power to detect small concordant effects via joint modeling and reduced multiplicity adjustment penalties. Hence, msFeaST provides interactive integration of the semi-quantitative experimental information with mass-spectral structural similarity information, enhancing the prioritization of features and feature sets during exploratory data analysis. AVAILABILITY AND IMPLEMENTATION: The msFeaST workflow is freely available through https://github.com/kevinmildau/msFeaST and built to work on MacOS and Linux systems.

Indexed as

MetabolomicsTandem Mass SpectrometryChromatography, LiquidCluster AnalysisLiquid Chromatography-Mass SpectrometrySoftware

Identifiers

PMID39348165
PMCPMC11471276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.